<DOC>
	<DOCNO>NCT02476318</DOCNO>
	<brief_summary>A prospective , multi-center study evaluate safety performance outcome ArterX Vascular Sealant use prophylactic sealing suture line anastomosis native vessel synthetic vascular graft .</brief_summary>
	<brief_title>A Study Evaluate Safety Performance ArterX™ Vascular Sealant Sealing Synthetic Arterial Grafts</brief_title>
	<detailed_description />
	<mesh_term>Vascular Diseases</mesh_term>
	<criteria>1 . The subject must ≥ 18 year old 2 . The subject must schedule surgical placement synthetic graft large vessel repair/ arterial reconstruction/ hemodialysis access . 3 . The subject child bear potential negative serum urine pregnancy test within 7 day index procedure . 4 . The subject willing able contact minimum 6 week follow . 5 . The subject guardian must provide write informed consent use form review approved Ethics Committee . 1 . The subject know hypersensitivity contraindication heparin , bovine seafood product . 2 . The subject history bleed diathesis coagulopathy , refuse blood transfusion . 3 . The subject currently enrol , another investigational device drug trail complete required followup period . 4 . ArterX Vascular Sealant use patient exhibit allergic reaction material shellfish bovine origin .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>